Telomerase inhibitor MST-312 is a new compound derived from epigallocatechin gallate (EGCG)[1]. Our resultsdemonstrated that 4 M MST-312 not only showed lower cytotoxicity, but also inhibited telomerase activity inHepG2 cells. Therefore, in our experiments, 4 M MST-312 was chosen to study radiosensitization and relatedmechanisms. -H2AX foci are considered as an indicator of DNA damages[2]. The immunofluorescence stainingresults showed the number of -H2AX foci in the pretreatment with MST-312 followed by 2 Gy X-ray irradiationgroup. However, as shown in Fig. 1, the formation of Rad51 foci in the combined treatment group was blockedoutside the nuclear of HepG2 cells, when compared with the irradiation alone group. JC-1 staining showed thatMST-312 pretreatment, followed by X-ray irradiation, caused increase of the green/red fluorescence intensity ratio(ΔΨm) compared with X-ray irradiation alone. Meanwhile, MST-312 pretreatment followed by X-ray irradiationelevated expression of p53 protein and decreased expression of caspase-3 as well as fraction of Bcl-2 / Bax.
展开▼
